CTMC
CTMC is a co-development accelerator formed by Resilience and MD Anderson Cancer
Center to fast-track the development and manufacturing of next-generation cell therapies
for cancer. Located in the heart of the Texas Medical Center, CTMC combines deep
expertise in TIL and CAR-T platforms with integrated manufacturing and regulatory
capabilities to accelerate the path from discovery to IND. As a true partner, we work sideby-
side with cell therapy innovators, advancing programs into the clinic faster and charting
a clear course to commercial readiness. Follow us on LinkedIn @ctmcplus to learn more.
